ZOETIS EXECUTIVE TEAM
Executive Vice President and Chief Financial Officer
Glenn David is Executive Vice President and Chief Financial Officer of Zoetis, the world leader in animal health medicines and vaccines. In this role, he is responsible for overseeing the financial management, planning and global operations for this $4.8 billion company.
With more than 20 years of experience in finance and operations, David has played a key role in leading the financial operations for Zoetis since its Initial Public Offering (IPO) in 2013. As senior vice president of Finance Operations for Zoetis, David led a diverse global team of finance professionals including financial planning, analysis and support across its 45 global markets, Treasury, Finance Shared Services and Global Operations. From April 2014 through August 2014, David served as acting Chief Financial Officer of Zoetis, overseeing financial management, reporting and shareholder relations and global procurement and operations.
Before the Zoetis IPO, David served in various financial roles at Pfizer, including vice president of Global Finance for Pfizer Animal Health and vice president of Finance for the U.S. Primary Care franchise. David also played important financial roles in Pfizer’s integration of the Pharmacia, Wyeth and King Pharmaceuticals’ acquisitions.
Prior to joining Pfizer in 1999, David gained valuable financial experience at Bankers Trust, Paine Webber and Credit Suisse.
David graduated magna cum laude with a bachelor’s degree in Finance from Binghamton University, and earned his MBA in Finance/Information Technology from New York University.
David resides in New Jersey with his wife and daughter.